Complications following upfront pancreatectomy with venous resection do not compromise adjuvant chemotherapy delivery and survival in pancreatic cancer
Upfront PVR has an acceptable risk profile and oncologic outcomes when adjuvant chemotherapy is administered. Survival and the delivery of adjuvant therapy do not appear to be negatively affected by complications.
Authors
- Samuele Grandi (ORCID: https://orcid.org/0000-0002-9257-0240)
- Giampaolo Perri (ORCID: https://orcid.org/0000-0002-2072-7114)
- Nicola Canitano (ORCID: https://orcid.org/0000-0003-3369-9084)
- Umberto Cillo (ORCID: https://orcid.org/0000-0002-2310-0245)
- Giovanni Marchegiani (ORCID: https://orcid.org/0000-0002-6824-4533)
- Muyue Liu
- Daniela Bassi (ORCID: https://orcid.org/0000-0001-9020-3853)
- Yuexiang Liang (ORCID: https://orcid.org/0000-0002-5201-8187)
- Riccardo Guastella
- Jianzhen Lin
- Zipeng Lu
- Riccardo Pellegrini (ORCID: https://orcid.org/0009-0006-0597-9360)
Institutions
- University of Padua (IT)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Langenbeck s Archives of Surgery
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1007/s00423-025-03933-z
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00